COVID booster cuts severe COVID risk by a third in patients with weak immune systems--study

Submitted by mike kraft on

Study: COVID booster cuts severe COVID risk by a third in patients with weak immune systems One dose of the updated, single-strain COVID-19 vaccine introduced last fall is 38% effective against hospitalization in the 7 to 59 days after receipt and 34% effective at 60 to 119 days in adults with weakened immune systems, yet uptake in this group is low, estimates a study published today in Morbidity and Mortality Weekly Report. CIDRAP

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report
Groups this Group Post belongs to: 
- Private group -